Probing the Role of the Covalent Linkage of Ferrocene into a Chloroquine Template
- 1 July 2006
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (15), 4707-4714
- https://doi.org/10.1021/jm060259d
Abstract
A new therapeutic approach to malaria led to the discovery of ferroquine (FQ, SR97276). To assess the importance of the linkage of the ferrocenyl group to a 4-aminoquinoline scaffold, two series of 4-aminoquinolines, structurally related to FQ, were synthesized. Evaluation of antimalarial activity, physicochemical parameters, and the beta-hematin inhibition property indicate that the ferrocene moiety has to be covalently flanked by a 4-aminoquinoline and an alkylamine. Current data reinforced our choice of FQ as a drug candidate.Keywords
This publication has 17 references indexed in Scilit:
- Novel Approaches to Antimalarial Drug DiscoveryInfectious Disorders - Drug Targets, 2006
- Current drug development portfolio for antimalarial therapiesCurrent Opinion in Pharmacology, 2005
- Opportunities and Challenges in Antiparasitic Drug DiscoveryNature Reviews Drug Discovery, 2005
- Effectiveness of Antimalarial DrugsNew England Journal of Medicine, 2005
- MalariaThe Lancet, 2005
- Insights into the Mechanism of Action of Ferroquine. Relationship between Physicochemical Properties and Antiplasmodial ActivityMolecular Pharmaceutics, 2005
- UPDATE ON THE CLINICAL DEVELOPMENT OF CANDIDATE MALARIA VACCINESThe American Journal of Tropical Medicine and Hygiene, 2004
- New amine and urea analogs of ferrochloroquine: synthesis, antimalarial activity in vitro and electrochemical studiesTetrahedron Letters, 2000
- Cyanohydridoborate anion as a selective reducing agentJournal of the American Chemical Society, 1971
- Lithium cyanohydridoborate, a versatile new reagentJournal of the American Chemical Society, 1969